HEPACAM and astrocytoma (excluding glioblastoma): A further support to this hypothesis is provided by the finding that in astrocytoma cells GlialCAM pathological mutations disrupt GlialCAM/Cx43 interactions, decreasing Cx43 stability at the plasma membrane [40].